Four weeks less, nearly same cure rate for hepatitis C: SGPGI-led study

The findings of the trial, conducted over more than a year and published in The Lancet recently, suggest that hepatitis C treatment could potentially be shortened by four weeks without a meaningful reduction in effectiveness. This could have implications for treatment programmes in India and other countries.



Source link